Identification Generic Name (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid DrugBank Accession Number DB08375 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-[(1R)-1-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-2-oxoethyl]-5-methylidene-2H-1,3-thiazine-4-carboxylic acid (DB08375) ×  Close Weight Average: 397.429  Monoisotopic: 397.051459995  Chemical Formula C 14 H 15 N 5 O 5 S 2 Synonyms Pcnotaxime group Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Penicillin-binding protein 1A Not Available Streptococcus pneumoniae (strain ATCC BAA-255 / R6) U Beta-lactamase Toho-1 Not Available Escherichia coli U Beta-lactamase Not Available Escherichia coli (strain K12) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 1,3-thiazines. These are organic compounds containing 1,3-thiazine, a six-member ring with a nitrogen and a sulfur atoms in ring positions 1 and 3 respectively, as well as two double bonds. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Thiazines Sub Class 1,3-thiazines Direct Parent 1,3-thiazines Alternative Parents Thiazoles  /  Heteroaromatic compounds  /  Ketimines  /  Isothioureas  /  Propargyl-type 1,3-dipolar organic compounds  /  Monocarboxylic acids and derivatives  /  Dialkylthioethers  /  Carboxylic acids  /  Carboximidic acids  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Aldehydes 
 
 
  show 4 more Substituents Aldehyde  /  Aromatic heteromonocyclic compound  /  Azacycle  /  Azole  /  Carbonyl group  /  Carboximidic acid  /  Carboximidic acid derivative  /  Carboxylic acid  /  Carboxylic acid derivative  /  Dialkylthioether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imine  /  Isothiourea  /  Ketimine  /  Meta-thiazine  /  Monocarboxylic acid or derivatives  /  Organic 1,3-dipolar compound  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Propargyl-type 1,3-dipolar organic compound  /  Thiazole  /  Thioether 
 
 
  show 17 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key NRYMPLKBKFIWQC-YVCCLBOHSA-N InChI InChI=1S/C14H15N5O5S2/c1-6-4-25-12(18-9(6)13(22)23)7(3-20)16-11(21)10(19-24-2)8-5-26-14(15)17-8/h3,5,7,12H,1,4H2,2H3,(H2,15,17)(H,16,21)(H,22,23)/b19-10-/t7-,12-/m1/s1 IUPAC Name (2R)-2-[(1R)-1-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-2-oxoethyl]-5-methylidene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid SMILES [H][C@@]1(SCC(=C)C(=N1)C(O)=O)[C@H](NC(=O)C(=N/OC)\C1=CSC(N)=N1)C=O References General References Not Available External Links PubChem Compound 131704308 PubChem Substance 99444846 ChemSpider 26328474 ZINC ZINC000015605562 PDBe Ligand CEF PDB Entries 1cef  /  1iyo  /  2c5w  /  2xd1  /  2zqa  /  3ixh  /  3m2k  /  3sh9  /  3upp  /  3vsl  …  
 
 
  show 15 more Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0892 mg/mL ALOGPS logP -0.14 ALOGPS logP 0.31 Chemaxon logS -3.6 ALOGPS pKa (Strongest Acidic) 2.64 Chemaxon pKa (Strongest Basic) 3.58 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 9 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 156.33 Å 2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 94.64 m 3 ·mol -1 Chemaxon Polarizability 37.57 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption - 0.7941 Blood Brain Barrier - 0.8795 Caco-2 permeable - 0.635 P-glycoprotein substrate Substrate 0.5 P-glycoprotein inhibitor I Non-inhibitor 0.8567 P-glycoprotein inhibitor II Non-inhibitor 0.9405 Renal organic cation transporter Non-inhibitor 0.8971 CYP450 2C9 substrate Non-substrate 0.8683 CYP450 2D6 substrate Non-substrate 0.824 CYP450 3A4 substrate Non-substrate 0.5956 CYP450 1A2 substrate Non-inhibitor 0.6771 CYP450 2C9 inhibitor Non-inhibitor 0.7044 CYP450 2D6 inhibitor Non-inhibitor 0.8898 CYP450 2C19 inhibitor Non-inhibitor 0.6694 CYP450 3A4 inhibitor Non-inhibitor 0.7209 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8778 Ames test Non AMES toxic 0.5623 Carcinogenicity Non-carcinogens 0.8573 Biodegradation Not ready biodegradable 0.9533 Rat acute toxicity 2.4710 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9885 hERG inhibition (predictor II) Non-inhibitor 0.9064    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Penicillin-binding protein 1A Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action Unknown General Function Penicillin binding Specific Function Cell wall formation. Gene Name pbpA Uniprot ID Q8DR59 Uniprot Name Penicillin-binding protein 1A Molecular Weight 79700.9 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  Beta-lactamase Toho-1 Kind Protein Organism Escherichia coli Pharmacological action Unknown General Function Beta-lactamase activity Specific Function Has strong cefotaxime-hydrolyzing activity. Gene Name bla Uniprot ID Q47066 Uniprot Name Beta-lactamase Toho-1 Molecular Weight 31446.6 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 3.  Beta-lactamase Kind Protein Organism Escherichia coli (strain K12) Pharmacological action Unknown General Function Beta-lactamase activity Specific Function This protein is a serine beta-lactamase with a substrate specificity for cephalosporins. Gene Name ampC Uniprot ID P00811 Uniprot Name Beta-lactamase Molecular Weight 41555.3 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:31 / Updated at June 12, 2020 16:52 